Celera Genomics Group (PE Corporation) / Paracel Inc.
2000 · Acquisition/Merger · $245M · Complete
Announcement Sentiment
50
Neutral / mixed
Celera Genomics completed acquisition of Paracel for ~$245M (closing-price valuation). Brought hardware/software for high-throughput search and manipulation of genetic-information databases. Strengthened Celera's bioinformatics platform during the human-genome publication race.
Did it work? Outcome assessment
Strategic verdict
Partially Achieved
Financial impact
Impaired/Written Down
Pipeline outcome
Assets Terminated
Assessment window: 10yr post-close.
Key facts
AnnouncedJun 05, 2000
ClosedJun 09, 2000
Deal value$245M
Deal typeAcquisition/Merger
Therapeutic areaGenomics tools (research)
IndicationsGenomics tools (research)
Key assetsBioinformatics hardware/software for genomic database search